Kuan Arthur 4
4 · CG Oncology, Inc. · Filed Oct 7, 2024
Insider Transaction Report
Form 4
Kuan Arthur
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-04+397,800→ 397,800 totalExercise: $36.63Exp: 2034-10-03→ Common Stock (397,800 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.